AMJEVITA
Live / Registered — Registered (as of 18 Apr 2023)
What this means for you
Registered since 18 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88697701
- Registration number
- 7031370
- Mark type
- Stylized text
- Filed
- 19 Nov 2019
- Published for opposition
- 18 Feb 2020
- Registered
- 18 Apr 2023
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and biosimilars for the treatment of autoimmune diseases and disorders; pharmaceutical preparations and biosimilars for the treatment of rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 17 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Feb 2023 — USE AMENDMENT FILED
- 23 Feb 2023 — TEAS STATEMENT OF USE RECEIVED
- 09 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2022 — SOU EXTENSION 5 GRANTED
- 29 Aug 2022 — SOU EXTENSION 5 FILED